Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

CSL Limited

CMXHFPNK
Healthcare
Biotechnology
$107.40
$0.00(0.00%)
U.S. Market opens in 9h 38m

CSL Limited Fundamental Analysis

CSL Limited (CMXHF) shows weak financial fundamentals with a PE ratio of 33.25, profit margin of 9.17%, and ROE of 7.56%. The company generates $15.7B in annual revenue with moderate year-over-year growth of 5.04%.

Key Strengths

Operating Margin25.72%
PEG Ratio-0.63
Current Ratio2.57

Areas of Concern

ROE7.56%
Cash Position2.39%
We analyze CMXHF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 52.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
52.6/100

We analyze CMXHF's fundamental strength across five key dimensions:

Efficiency Score

Weak

CMXHF struggles to generate sufficient returns from assets.

ROA > 10%
3.80%

Valuation Score

Moderate

CMXHF shows balanced valuation metrics.

PE < 25
33.25
PEG Ratio < 2
-0.63

Growth Score

Excellent

CMXHF delivers strong and consistent growth momentum.

Revenue Growth > 5%
5.04%
EPS Growth > 10%
13.35%

Financial Health Score

Excellent

CMXHF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.67
Current Ratio > 1
2.57

Profitability Score

Weak

CMXHF struggles to sustain strong margins.

ROE > 15%
7.56%
Net Margin ≥ 15%
9.17%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CMXHF Expensive or Cheap?

P/E Ratio

CMXHF trades at 33.25 times earnings. This suggests a premium valuation.

33.25

PEG Ratio

When adjusting for growth, CMXHF's PEG of -0.63 indicates potential undervaluation.

-0.63

Price to Book

The market values CSL Limited at 2.56 times its book value. This may indicate undervaluation.

2.56

EV/EBITDA

Enterprise value stands at 7.11 times EBITDA. This is generally considered low.

7.11

How Well Does CMXHF Make Money?

Net Profit Margin

For every $100 in sales, CSL Limited keeps $9.17 as profit after all expenses.

9.17%

Operating Margin

Core operations generate 25.72 in profit for every $100 in revenue, before interest and taxes.

25.72%

ROE

Management delivers $7.56 in profit for every $100 of shareholder equity.

7.56%

ROA

CSL Limited generates $3.80 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.80%

Following the Money - Real Cash Generation

Operating Cash Flow

CSL Limited produces operating cash flow of $3.78B, showing steady but balanced cash generation.

$3.78B

Free Cash Flow

CSL Limited generates strong free cash flow of $3.19B, providing ample flexibility for dividends, buybacks, or growth.

$3.19B

FCF Per Share

Each share generates $6.58 in free cash annually.

$6.58

FCF Yield

CMXHF converts 6.62% of its market value into free cash.

6.62%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

33.25

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.63

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.56

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.06

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.67

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.57

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.08

vs 25 benchmark

ROA

Return on assets percentage

0.04

vs 25 benchmark

ROCE

Return on capital employed

0.12

vs 25 benchmark

How CMXHF Stacks Against Its Sector Peers

MetricCMXHF ValueSector AveragePerformance
P/E Ratio33.2529.45 Worse (Expensive)
ROE7.56%779.00% Weak
Net Margin9.17%-24936.00% (disorted) Weak
Debt/Equity0.670.26 Weak (High Leverage)
Current Ratio2.574.65 Strong Liquidity
ROA3.80%-19344.00% (disorted) Weak

CMXHF outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CSL Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

53.84%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

29.56%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

29.85%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ